HUP0101653A2 - Az epesavak zsírsavszármazékai valamint egyéb epesavszármazékok és ezeket tartalmazó gyógyszerkészítmények - Google Patents
Az epesavak zsírsavszármazékai valamint egyéb epesavszármazékok és ezeket tartalmazó gyógyszerkészítményekInfo
- Publication number
- HUP0101653A2 HUP0101653A2 HU0101653A HUP0101653A HUP0101653A2 HU P0101653 A2 HUP0101653 A2 HU P0101653A2 HU 0101653 A HU0101653 A HU 0101653A HU P0101653 A HUP0101653 A HU P0101653A HU P0101653 A2 HUP0101653 A2 HU P0101653A2
- Authority
- HU
- Hungary
- Prior art keywords
- acid derivatives
- bile
- pharmaceutical compositions
- fatty acid
- bile acids
- Prior art date
Links
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical class C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 title 1
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 title 1
- 239000003613 bile acid Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J9/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of more than two carbon atoms, e.g. cholane, cholestane, coprostane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Gastroenterology & Hepatology (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fats And Perfumes (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IL12399898A IL123998A (en) | 1998-04-08 | 1998-04-08 | Conjugates of bile salts and pharmaceutical preparations containing them |
| PCT/IL1999/000173 WO1999052932A1 (en) | 1998-04-08 | 1999-03-25 | Fatty acid derivatives of bile acids and bile acid derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| HUP0101653A2 true HUP0101653A2 (hu) | 2001-12-28 |
| HUP0101653A3 HUP0101653A3 (en) | 2002-02-28 |
| HU229513B1 HU229513B1 (en) | 2014-01-28 |
Family
ID=11071405
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0101653A HU229513B1 (en) | 1998-04-08 | 1999-03-25 | Fatty acid derivatives of bile acids and bile acid derivatives |
Country Status (25)
| Country | Link |
|---|---|
| US (3) | US6395722B1 (hu) |
| EP (1) | EP1071702B1 (hu) |
| JP (1) | JP5031942B2 (hu) |
| KR (1) | KR100615560B1 (hu) |
| CN (1) | CN100386339C (hu) |
| AT (1) | ATE222923T1 (hu) |
| AU (1) | AU742944B2 (hu) |
| BR (1) | BRPI9909908B8 (hu) |
| CA (1) | CA2325933C (hu) |
| CZ (1) | CZ300824B6 (hu) |
| DE (1) | DE69902647T2 (hu) |
| DK (1) | DK1071702T3 (hu) |
| EA (1) | EA003392B1 (hu) |
| ES (1) | ES2183526T3 (hu) |
| HU (1) | HU229513B1 (hu) |
| ID (1) | ID26042A (hu) |
| IL (1) | IL123998A (hu) |
| NO (1) | NO316875B1 (hu) |
| NZ (1) | NZ507309A (hu) |
| PL (1) | PL199271B1 (hu) |
| PT (1) | PT1071702E (hu) |
| SI (1) | SI1071702T1 (hu) |
| TR (1) | TR200002876T2 (hu) |
| UA (1) | UA70318C2 (hu) |
| WO (1) | WO1999052932A1 (hu) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL123998A (en) * | 1998-04-08 | 2004-09-27 | Galmed Int Ltd | Conjugates of bile salts and pharmaceutical preparations containing them |
| IL142650A (en) | 1998-04-08 | 2007-06-03 | Galmed Int Ltd | Use of bile acid conjugates or bile salts and fatty acids or fatty acids in the preparation of pharmaceuticals for lowering cholesterol, for the treatment of fatty liver and for the treatment of hyperglycemia and diabetes |
| US20030083231A1 (en) * | 1998-11-24 | 2003-05-01 | Ahlem Clarence N. | Blood cell deficiency treatment method |
| US8975246B2 (en) | 2001-04-17 | 2015-03-10 | Galmed Research And Development Ltd. | Bile acid or bile salt fatty acid conjugates |
| US7053076B2 (en) | 2001-08-29 | 2006-05-30 | Xenoport, Inc. | Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| ITMI20021025A1 (it) * | 2002-05-14 | 2003-11-14 | Nicox Sa | Farmaci per il trattamento acuto di disfunzioni del circolo venoso epatico e portale |
| US20080026077A1 (en) * | 2002-11-12 | 2008-01-31 | John Hilfinger | Methods and compositions of gene delivery agents for systemic and local therapy |
| US7906137B2 (en) * | 2004-05-21 | 2011-03-15 | Mediplex Corporation, Korea | Delivery agents for enhancing mucosal absorption of therapeutic agents |
| US8304383B2 (en) * | 2005-11-22 | 2012-11-06 | Atheronova Operations, Inc. | Dissolution of arterial plaque |
| US20090035348A1 (en) * | 2005-11-22 | 2009-02-05 | Z & Z Medical Holdings, Inc. | Dissolution of arterial plaque |
| WO2007084549A2 (en) * | 2006-01-20 | 2007-07-26 | Filiberto Zadini | Drug-eluting stent with atherosclerotic plaques dissolving pharmacological preparation |
| US20070212470A1 (en) * | 2006-03-13 | 2007-09-13 | Nutracea | Therapeutic uses of an anti-cancer composition derived from rice bran |
| US20080038385A1 (en) * | 2006-03-13 | 2008-02-14 | Nutracea | Therapeutic uses of an anti-cancer composition derived from rice bran |
| EP2043451B1 (en) * | 2006-07-18 | 2012-03-21 | Symrise AG | Cyclodextrin blends with crystal growth inhibitors |
| WO2008131419A2 (en) | 2007-04-23 | 2008-10-30 | Alnylam Pharmaceuticals, Inc. | Glycoconjugates of rna interference agents |
| US20080287429A1 (en) * | 2007-05-15 | 2008-11-20 | Z & Z Medical Holdings, Inc. | Dissolution of Arterial Cholesterol Plaques by Pharmacologically Induced Elevation of Endogenous Bile Salts |
| PT2182954T (pt) * | 2007-07-25 | 2019-02-06 | Univ Graz Medizinische | Utilização de ácidos nor-biliares no tratamento de arteriosclerose |
| CN101367859B (zh) * | 2007-08-17 | 2011-05-11 | 中国人民解放军军事医学科学院毒物药物研究所 | 脂肪酸胆汁酸偶合物及其医药用途 |
| CZ301037B6 (cs) * | 2007-09-06 | 2009-10-21 | Vysoká škola chemicko-technologická v Praze | Amidové konjugáty steroidních a žlucových kyselin s D-glukosaminem a zpusob jejich prípravy |
| WO2009082606A2 (en) | 2007-12-04 | 2009-07-02 | Alnylam Pharmaceuticals, Inc. | Folate conjugates |
| WO2009082607A2 (en) | 2007-12-04 | 2009-07-02 | Alnylam Pharmaceuticals, Inc. | Targeting lipids |
| US20100021538A1 (en) * | 2008-02-29 | 2010-01-28 | Youngro Byun | Pharmaceutical compositions containing heparin derivatives |
| CA2721183C (en) | 2008-04-11 | 2019-07-16 | Alnylam Pharmaceuticals, Inc. | Site-specific delivery of nucleic acids by combining targeting ligands with endosomolytic components |
| US9340569B2 (en) | 2008-11-03 | 2016-05-17 | Tufts University | Methods and compositions for inhibiting clostridium difficile spore germination and outgrowth |
| WO2010086864A1 (en) * | 2009-02-02 | 2010-08-05 | Galmed International Ltd. | Methods and compositions for treating alzheimer's disease |
| GB2480632A (en) | 2010-05-25 | 2011-11-30 | Kythera Biopharmaceuticals Inc | Preparation of 12-keto and 12-alpha-hydroxy steroids |
| CN102115486B (zh) * | 2009-12-30 | 2015-06-03 | 上海特化医药科技有限公司 | 一种3-β-花生酰胺基-7α,12α,5β-胆烷-24-羧酸的制备方法 |
| EP3138850B8 (en) * | 2011-06-16 | 2019-09-11 | Allergan Sales, LLC | Compositions containing deoxycholic acid and 10% deionized water in ethanol, directed to the purification of deoxycholic acid |
| US20160175324A1 (en) * | 2013-08-08 | 2016-06-23 | Galderm Therapeutics Ltd. | Anti-acne compositions comprising bile acid-fatty acid conjugates |
| US11571431B2 (en) | 2013-12-04 | 2023-02-07 | Galmed Research And Development Ltd | Aramchol salts |
| US20160304553A1 (en) * | 2013-12-04 | 2016-10-20 | Galmed Research & Development Ltd. | Aramchol salts |
| CN106413719A (zh) * | 2014-06-01 | 2017-02-15 | 盖尔梅德研究与发展有限公司 | 用于治疗脂肪营养不良的脂肪酸胆汁酸缀合物 |
| JOP20200092A1 (ar) | 2014-11-10 | 2017-06-16 | Alnylam Pharmaceuticals Inc | تركيبات iRNA لفيروس الكبد B (HBV) وطرق لاستخدامها |
| US10849911B2 (en) | 2015-06-10 | 2020-12-01 | Galmed Research And Development Ltd. | Low dose compositions of Aramachol salts |
| IL243707A0 (en) | 2016-01-20 | 2016-05-01 | Galmed Res And Dev Ltd | Treatment to regulate the microbiota in the intestine |
| CN106496300B (zh) * | 2016-10-19 | 2018-05-18 | 上海博志研新药物技术有限公司 | 花生胆酸及其中间体的制备方法 |
| US11197870B2 (en) | 2016-11-10 | 2021-12-14 | Galmed Research And Development Ltd | Treatment for hepatic fibrosis |
| US20190275061A1 (en) * | 2016-11-10 | 2019-09-12 | Galmed Research And Development Ltd | Inhibition of fibrosis in non alcohol fatty liver disease patients |
| US11324820B2 (en) | 2017-04-18 | 2022-05-10 | Alnylam Pharmaceuticals, Inc. | Methods for the treatment of subjects having a hepatitis b virus (HBV) infection |
| US11136347B2 (en) | 2017-06-07 | 2021-10-05 | Crystal Pharmaceutical (Suzhou) Co., Ltd. | Crystalline forms of a fatty acid bile acid conjugate, preparation method thereof and use thereof |
| EA202190528A1 (ru) | 2018-08-13 | 2021-04-23 | Элнилэм Фармасьютикалз, Инк. | КОМПОЗИЦИИ АГЕНТОВ дцРНК ВИРУСА ГЕПАТИТА B (HBV) И СПОСОБЫ ИХ ПРИМЕНЕНИЯ |
| IT202000000328A1 (it) | 2020-01-10 | 2021-07-10 | Ice S P A | Metodo di preparazione dell'aramchol |
| CN114524857B (zh) * | 2022-02-22 | 2023-06-30 | 中国科学院微生物研究所 | 胆酸衍生物及其应用 |
| CN116687850A (zh) | 2022-02-24 | 2023-09-05 | 甘莱制药有限公司 | 包含环状膦酸酯化合物的药物组合物及其制备方法与用途 |
| WO2023227723A1 (en) * | 2022-05-26 | 2023-11-30 | Pharmazell Gmbh | An improved process for the preparation of aramchol and salts thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3856953A (en) * | 1973-05-15 | 1974-12-24 | Intellectual Property Dev Corp | Method of treating fatty liver |
| IT1167478B (it) * | 1981-07-24 | 1987-05-13 | Carlo Scolastico | Derivati dell'acido ursodesossicolico |
| IT1167479B (it) * | 1981-07-24 | 1987-05-13 | Carlo Scolastico | Derivati dell'acido chenodesossicolico |
| DE3930696A1 (de) * | 1989-09-14 | 1991-03-28 | Hoechst Ag | Gallensaeurederivate, verfahren zu ihrer herstellung, verwendung als arzneimittel |
| IL123998A (en) * | 1998-04-08 | 2004-09-27 | Galmed Int Ltd | Conjugates of bile salts and pharmaceutical preparations containing them |
| DE19824123A1 (de) * | 1998-05-29 | 1999-12-02 | Hoechst Marion Roussel De Gmbh | Gallensäurederivat, Verfahren zu deren Herstellung, diese Verbindungen enthaltende Arzneimittel und deren Verwendung |
-
1998
- 1998-04-08 IL IL12399898A patent/IL123998A/en not_active IP Right Cessation
-
1999
- 1999-03-25 AT AT99912026T patent/ATE222923T1/de active
- 1999-03-25 PL PL343360A patent/PL199271B1/pl unknown
- 1999-03-25 DE DE69902647T patent/DE69902647T2/de not_active Expired - Lifetime
- 1999-03-25 JP JP2000543488A patent/JP5031942B2/ja not_active Expired - Lifetime
- 1999-03-25 HU HU0101653A patent/HU229513B1/hu unknown
- 1999-03-25 KR KR1020007010903A patent/KR100615560B1/ko not_active IP Right Cessation
- 1999-03-25 CN CNB998049034A patent/CN100386339C/zh not_active Expired - Lifetime
- 1999-03-25 ES ES99912026T patent/ES2183526T3/es not_active Expired - Lifetime
- 1999-03-25 TR TR2000/02876T patent/TR200002876T2/xx unknown
- 1999-03-25 CA CA002325933A patent/CA2325933C/en not_active Expired - Lifetime
- 1999-03-25 BR BRPI9909908A patent/BRPI9909908B8/pt not_active IP Right Cessation
- 1999-03-25 NZ NZ507309A patent/NZ507309A/xx not_active IP Right Cessation
- 1999-03-25 PT PT99912026T patent/PT1071702E/pt unknown
- 1999-03-25 ID IDW20001998A patent/ID26042A/id unknown
- 1999-03-25 AU AU30515/99A patent/AU742944B2/en not_active Expired
- 1999-03-25 SI SI9930142T patent/SI1071702T1/xx unknown
- 1999-03-25 CZ CZ20003625A patent/CZ300824B6/cs not_active IP Right Cessation
- 1999-03-25 EA EA200000888A patent/EA003392B1/ru not_active IP Right Cessation
- 1999-03-25 UA UA2000095546A patent/UA70318C2/uk unknown
- 1999-03-25 EP EP99912026A patent/EP1071702B1/en not_active Expired - Lifetime
- 1999-03-25 DK DK99912026T patent/DK1071702T3/da active
- 1999-03-25 WO PCT/IL1999/000173 patent/WO1999052932A1/en active IP Right Grant
-
2000
- 2000-09-29 US US09/675,656 patent/US6395722B1/en not_active Expired - Lifetime
- 2000-10-04 NO NO20004998A patent/NO316875B1/no not_active IP Right Cessation
- 2000-10-23 US US09/693,928 patent/US6384024B1/en not_active Expired - Lifetime
-
2002
- 2002-02-21 US US10/078,671 patent/US6589946B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0101653A3 (en) | Fatty acid derivatives of bile acids and bile acid derivatives and pharmaceutical compositions thereof | |
| HUP0202342A3 (en) | Pharmaceutical and nutritional compositions containing essential fatty acids and homocysteine-lowering agents | |
| HUP0100178A3 (en) | Tetrahydro-naphtiridinyl-imidazolydinyl-carboxylic acid derivatives and pharmaceutical compositions thereof | |
| IL141063A (en) | Derivatives of pyrrolidine-2-carboxylic acid and piperidine-2-carboxylic acids and pharmaceutical compositions comprising said derivatives for treating infertility | |
| HUP0200111A3 (en) | Use of essential fatty acids for preparation of pharmaceutical composition available in the prevention of cardiovascular events | |
| IL128600A0 (en) | Propionic acid derivatives and pharmaceutical compositions containing them | |
| AU6236900A (en) | Method of preparing dimeric fatty acids and/or esters thereof | |
| HUP0002701A3 (en) | Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides | |
| AU4133193A (en) | Compositions of digestive enzymes and salts of bile acids and process for preparation thereof | |
| HUP0003761A2 (en) | Substituted alkanohydroxamic acids and pharmaceutical compositions containing them | |
| IL145789A0 (en) | Derivatives of propionic acid, their preparation and pharmaceutical compositions containing them | |
| HU9501561D0 (en) | Fatty acid derivatives and pharmaceutical compositions containing them | |
| IL117265A0 (en) | Benzazepine- benzoxazepine- and benzothiazepine-n-acetic acid derivatives their preparation and pharmaceutical compositions containing them | |
| HUP0001269A3 (en) | 2-oxo-1-azetidine sulfonic acid derivatives and combined pharmaceutical compositions thereof | |
| HUP0105160A3 (en) | Complex of ras-farnesyltransferase inhibitor and sulfobutylether-7-betha-cyclodextrin or 2-hydroxypropyl-betha-cyclodextrin and method for its preparation and pharmaceutical compositions containing them | |
| AU3591301A (en) | Ester derivatives of dimethylpropionic acid and pharmacetuical compositions containing them | |
| HUP0400801A3 (en) | Pharmaceutical compositions containing bile acid or bile salt fatty acid conjugates and their use | |
| AU2111095A (en) | Salts of omega-3-polyunsaturated fatty acids and pharmaceutical formulations containing them | |
| IL116480A0 (en) | Acetic acid deriratives their preparation and pharmaceutical compositions containing them | |
| EP0689835A3 (en) | Composition containing an amino acid mixture and at least one N-3 fatty acid | |
| HUP9700810A3 (en) | Acids and esters of diosmetin and pharmaceutical compositions containing them | |
| ZA9811655B (en) | Phenylaminoalkylcarboxylic acid derivatives and pharmaceutical compositions comprising the same | |
| HUP0001534A3 (en) | Phospholipid derivatives of phosphono-carboxylic acids and pharmaceutical compositions containing them | |
| GB2244918B (en) | Pharmaceutical compositions comprising somatostatin and cholanic acid derivatives | |
| HUP0103570A3 (en) | Propanolamine derivatives linked with bile acid used for treating disorders of the lipid metabolism and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB9A | Succession in title |
Owner name: GALMED RESEARCH AND DEVELOPMENT LTD., IL Free format text: FORMER OWNER(S): GALMED INTERNATIONAL LIMITED, MT |